Bafna Pharmaceuticals Limited (NSE:BAFNAPH)
India · Delayed Price · Currency is INR 454.50
+6.95 (1.55%)
Nov 6, 2026, 3:15 PM IST
Bafna Pharmaceuticals Market Cap
Bafna Pharmaceuticals has a market cap or net worth of 10.75 billion as of November 6, 2026. It is the 23,955th most valuable company in the world and the 1,559th biggest in India. Its market cap has increased by 187.04% in one year.
Market Cap
10.75B
Enterprise Value
11.11B
Revenue
1.43B
Global Rank
Country Rank
#1,559 India
PE Ratio
140.10
ChartMarket Cap Chart
Since March 2, 2020, Bafna Pharmaceuticals's market cap has increased from 10.88M to 10.75B, an increase of 98,704.33%. That is a compound annual growth rate of 180.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 10.75B | 201.55% |
| Dec 31, 2025 | 3.57B | 91.03% |
| Dec 31, 2024 | 1.87B | -14.24% |
| Dec 29, 2023 | 2.18B | -8.68% |
| Dec 30, 2022 | 2.38B | -33.96% |
| Dec 31, 2021 | 3.61B | -10.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ind-Swift Laboratories | 32.44B |
| Solara Active Pharma Sciences | 31.08B |
| Sakar Healthcare | 21.80B |
| Indoco Remedies | 19.75B |
| Windlas Biotech | 17.97B |
| Beta Drugs | 17.94B |
| Jagsonpal Pharmaceuticals | 14.59B |
| Anlon Healthcare | 14.17B |